首页> 美国卫生研究院文献>other >Predictive and Prognostic Value of Metabolic Tumor Volume (MTV) in Patients with Laryngeal Carcinoma Treated by Radiotherapy (RT) / Concurrent Chemoradiotherapy (CCRT)

【2h】

Predictive and Prognostic Value of Metabolic Tumor Volume (MTV) in Patients with Laryngeal Carcinoma Treated by Radiotherapy (RT) / Concurrent Chemoradiotherapy (CCRT)

机译：放疗（RT）/同期放化疗（CCRT）对喉癌患者代谢性肿瘤体积（MTV）的预测和预后价值

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

PurposeTo evaluate the predictive and prognostic value of pretreatment metabolic tumor volume (MTV) in patients with treated by radiotherapy (RT) or concurrent chemoradiotherapy (CCRT).

机译：目的评估经放疗（RT）或同时放化疗的患者的治疗前代谢性肿瘤体积（MTV）的预测和预后价值。

著录项

期刊名称 other
作者
Kenichiro Yabuki; Osamu Shiono; Masanori Komatsu; Daisuke Sano; Goshi Nishimura; Masahiro Takahashi; Takahide Taguchi; Tomio Inoue; Nobuhiko Oridate;
展开▼
作者单位

展开▼
年(卷),期 -1(10),2
年度 -1
页码 e0117924
总页数 12
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Can adaptive threshold-based metabolic tumor volume (MTV) and lean body mass corrected standard uptake value (SUL) predict prognosis in head and neck cancer patients treated with definitive radiotherapy/chemoradiotherapy? [J] . Akagunduz Ozlem Ozkaya, Savas Recep, Yalman Deniz, Nuclear Medicine and Biology . 2015,第11期

机译：适应性基于阈值的代谢肿瘤体积（MTV）和瘦体重校正的标准摄取值（SUL）是否可以预测接受定性放疗/放化疗的头颈癌患者的预后？
2. Pre-therapeutic metabolic Tumor Volume (MTV) in (18) F-FDG-PET/CT as a prognostic Factor in Patients with Stage IIIA-IIIB NSCLC before Trimodal Therapy or definitive Chemoradiotherapy - Results of Phase 3 Study [J] . Guberina M., Eberhardt W. E. E., Stuschke M., Strahlentherapie und Onkologie . 2018,第Suppla1期

机译：（18）F-FDG-PET / CT中的治疗性代谢肿瘤体积（MTV）作为患者IIIA-IIIB NSCLC患者的预后因子，PRIMODAL治疗或明确的化学疗法 - 第3期研究结果
3. Prognostic value of metabolic tumor volume and total lesion glycolysis in esophageal carcinoma patients treated with definitive chemoradiotherapy [J] . Yildirim Berna A., Torun Nese, Guler Ozan C., Nuclear Medicine Communications . 2018,第6期

机译：食管癌患者代谢肿瘤体积及总损伤糖酵解治疗的预后价值
4. Laryngo-pharyngeal function after concurrent chemoradiotherapy in patients with laryngeal cancer or hypopharyngeal cancer. [C] . Furukawa Madoka K., Kubota A., Yagi H., World Congress for Bronchology . 2011

机译：喉切咽喉咽喉咽喉咽喉疗法患者喉癌或白血病患者后喉咽咽。
5. Computational investigation of biological dose-volume outcome predictors in 29 canine nasal tumor patients treated with stereotactic radiation therapy [D] . McBeth, Rafe 2012

机译：立体定向放射疗法治疗29例鼻鼻肿瘤患者的生物剂量-体积结局预测因子的计算研究
6. Development and Validation of Prognostic Nomograms Based on Gross Tumor Volume and Cervical Nodal Volume for Nasopharyngeal Carcinoma Patients With Concurrent Chemoradiotherapy [O] . Cui-Dai Zhang, Mei Li, Ying-Ji Hong, 2021

机译：基于总肿瘤癌患者的肿瘤癌患者患者的颈部颈瘤患者的预后载体的开发与验证
7. Predictive and prognostic value of metabolic tumor volume (MTV) in patients with laryngeal carcinoma treated by radiotherapy (RT) / concurrent chemoradiotherapy (CCRT). [O] . Kenichiro Yabuki, Osamu Shiono, Masanori Komatsu, 2015

机译：通过放疗（RT）/同步放化疗（CCRT）治疗的喉癌患者代谢肿瘤体积（mTV）的预测和预后价值。

Predictive and Prognostic Value of Metabolic Tumor Volume (MTV) in Patients with Laryngeal Carcinoma Treated by Radiotherapy (RT) / Concurrent Chemoradiotherapy (CCRT)

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅